Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
The American Journal of Pathology
|
January 27, 2006
A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys
Yulia Vugmeyster, Dhaya Seshasayee, Wesley Chang, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
November 19, 2003
Quantitative comparison of long-wavelength Alexa Fluor dyes to Cy dyes: fluorescence of the dyes and their bioconjugates
Judith E Berlier, Anca Rothe, Gayle Buller, et al.
Cancer Cell
|
July 22, 2014
Apo2L/TRAIL and the death receptor 5 agonist antibody AMG 655 cooperate to promote receptor clustering and antitumor activity
Jonathan D Graves, Jennifer J Kordich, Tzu-Hsuan Huang, et al.
Blood
|
March 22, 2007
Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma
Andrew G Polson, Shang-Fan Yu, Kristi Elkins, et al.
Cancer Research
|
March 5, 2009
Antibody-drug conjugates for the treatment of non-Hodgkin's lymphoma: target and linker-drug selection
Andrew G Polson, Jill Calemine-Fenaux, Pamela Chan, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
The American Journal of Pathology
|
January 27, 2006
A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys
Yulia Vugmeyster, Dhaya Seshasayee, Wesley Chang, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
November 19, 2003
Quantitative comparison of long-wavelength Alexa Fluor dyes to Cy dyes: fluorescence of the dyes and their bioconjugates
Judith E Berlier, Anca Rothe, Gayle Buller, et al.
Cancer Cell
|
July 22, 2014
Apo2L/TRAIL and the death receptor 5 agonist antibody AMG 655 cooperate to promote receptor clustering and antitumor activity
Jonathan D Graves, Jennifer J Kordich, Tzu-Hsuan Huang, et al.
Blood
|
March 22, 2007
Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma
Andrew G Polson, Shang-Fan Yu, Kristi Elkins, et al.
Cancer Research
|
March 5, 2009
Antibody-drug conjugates for the treatment of non-Hodgkin's lymphoma: target and linker-drug selection
Andrew G Polson, Jill Calemine-Fenaux, Pamela Chan, et al.
Page
of 2